Rationale and objective:The major objective of treatment in glaucomatous disease is the decrease of intraocular pressure while maintaining the patient's vision and quality of life. Despite therapeutic possibilities, some cases of glaucoma remain refractory to treatment with the maintenance of elevated intraocular pressure and further progression of the disease. Artificial drainage systems, Ahmed valve, is a treatment alternative for refractory glaucoma when medical therapy, laser or conventional surgery have shown no results.
Introduction
Increased ocular pressure (over 22 mmHg) determines, in time, irreversible damage to the optic nerve.
During vitreoretinal surgery, silicone oil is sometimes used for a long term tamponade. This silicone oil is removed after 3-4 months, as it can give rise to various complications, including glaucoma. The mechanism described in the development of glaucoma in patients with silicone oil tamponade consists of silicone oil pupillary block [3, 4] .
Even after these patients have had peripheral iridectomy, the development rate of secondary glaucoma is reported to be between 5.9% and 56%. [1] [2] [3] The mechanisms of increased intraocular pressure are complex, the blockage of the angle with emulsified oil being an important one. Most of these cases are handled by extracting the silicon oil (risk of retina redetachment) and management of glaucoma. Trabeculectomy has a poor prognosis in patients with removal of silicone oil because of the high risk of recurrence of retinal detachment due to hypotony. Fluctuations of the intraocular pressure were observed during the day with elevated IOP in the morning and the presence of emulsified oil at a slight angle examination. Patient also presented visual field loss [7, 8] .
Case report
We decided to implant an Ahmed valve in the RE. The usual technique with positioning the implant in the superior temporal quadrant with scleral flap (patient had a good conjunctiva and sclera) is used.
Postoperative, no complications were noted. Patient presented dyplopia during eye movement that disappeared in the primary position of the eyeballs.
At discharge, the valve was covered with conjunctiva; the tube was present in the anterior chamber, with clear aqueous humor. The valve was functional, RE IOP 10 mmHg without medication.
The recommendations were topical treatment with antibiotic and corticosteroid at RE; at LE, anti glaucoma medical treatment with prostaglandin analogues associated with beta-blockers and carbonic anhydrase inhibitors. 
Discussions
This is the case of a patient with low grade myopia, who, after cataract surgery, developed retinal detachment. The retina was successfully reattached but, as a complication of intraocular presence of silicone oil, secondary glaucoma developed. Glaucoma did not respond to traditional medication.
The IOP was elevated in the morning, probably related to the supine position and the presence of emulsified oil bubbles at the angle. The particularity of the case is that the patient had a cluster angle, with pigmentary dispersion and anterior synechiae at BE. An Ahmed valve implanted was successfully performed, using a traditional operative technique; postoperative complications were minimal and resolved.
Conclusions
The Ahmed valve may be a solution for patients with secondary glaucoma after vitroretinal surgery when medication is not effective. Because of the valve mechanism, intraocular pressure does not decrease as fast as it does after trabeculectomy, so the risk of retinal redetachment is lower. Most surgeons recommend Ahmed valve as a last therapeutic solution for refractory glaucoma after repeated trabeculectomy. During the three decades that have passed after the approval of this device, developed by Molteno, the indications for artificial devices changed. Currently, artificial drainage systems can be used successfully for secondary glaucoma after vitreoretinal surgery, neovascular glaucoma and inflammatory glaucoma.
